Adriaan Voors

cardiologist/professor

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adriaan Voors is a Professor of Cardiology at the University Medical Center Groningen in the Netherlands. His research focuses on heart failure, including the identification of congestion phenotypes and the association of cardiac function with clinical outcomes. He has contributed significantly to studies involving machine learning in acute heart failure, as well as the effects of therapies in diverse populations with type 2 diabetes. His recent publications explore various aspects of heart failure and atrial stress biomarkers.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Jozine ter Maaten

University Medical Center Groningen

NETHERLANDS

View details

Kevin Damman

University of Groningen

NETHERLANDS

View details

Sanne Peters

Imperial College London

UNITED KINGDOM

View details

Leong Ng

Professor of Medicine and Therapeutics

University of Leicester

UNITED KINGDOM

View details

Carolyn SP Lam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adriaan Voors

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Association Between Endothelial Alterations, Cardiac Function, and Outcomes From Health to Heart Failure: Insight From the STANISLAS, MEDIA‐DHF, and BIOSTAT‐CHF Cohorts

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials

Identifying congestion phenotypes using unsupervised machine learning in acute heart failure

Serially measured urinary albumin excretion is strongly associated with incident heart failure with preserved ejection fraction

Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Reply to the letter regarding the article ‘Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT‐CHF (European) study with the ASIAN‐HF registry’

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Characteristics and Clinical Outcomes of Patients Hospitalized for Acute Heart Failure Who Develop Atrial Fibrillation or Convert to Sinus Rhythm

Sex-related similarities and differences in responses to heart failure therapies

Renal function and natriuresis‐guided diuretic therapy – a pre‐specified analysis from the PUSH‐AHF trial

Immunomodulation and immunopharmacology in heart failure

Novel recommendations for the treatment of patients with heart failure: 2023 Focused Update of the 2021 ESC Heart Failure Guidelines

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study

Heart failure medication: moving from evidence generation to implementation

Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF

Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial

Temporal Trends and Clinical Trial Characteristics Associated With the Inclusion of Women in Heart Failure Trial Steering Committees: A Systematic Review

Collaborators (5)

Jozine ter Maaten

Kevin Damman

Sanne Peters

Leong Ng

Carolyn SP Lam

Make your next move.